Takeda Pharmaceutical (4502.T) Price-to-Earnings (P/E) Ratio
Price: $4545
Market Cap: $7.20T
Avg Volume: 4.12M
Market Cap: $7.20T
Avg Volume: 4.12M
Country: JP
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Takeda Pharmaceutical's P/E ratios across different time periods:
- TTM: 34.58
- Annual: 45.16
- Quarterly: 69.56
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 0.89
- Price-to-Sales (P/S) Ratio: 1.53
Annual Ratios
Takeda Pharmaceutical Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
34.58
P/B Ratio (Annual)
0.89
P/S Ratio (Annual)
1.53
Takeda Pharmaceutical Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | 45.16 | 0.89 | 1.53 |
| 2023 | 21.29 | 1.06 | 1.68 |
| 2022 | 23.77 | 0.96 | 1.53 |
| 2021 | 16.55 | 1.20 | 1.95 |
| 2020 | 116.44 | 1.09 | 1.57 |
| 2019 | 65.76 | 1.39 | 3.42 |
| 2018 | 43.50 | 4.07 | 4.59 |
| 2017 | 71.36 | 4.33 | 4.74 |
| 2016 | 100.49 | 4.13 | 4.46 |
| 2015 | -64.55 | 4.40 | 5.29 |
| 2014 | 71.94 | 3.11 | 4.54 |
| 2013 | 57.13 | 3.47 | 4.81 |
| 2012 | 46.05 | 2.84 | 3.79 |
| 2011 | 24.55 | 2.91 | 4.29 |
| 2010 | 21.68 | 3.04 | 4.40 |
Related Metrics
Explore detailed financial metrics and analysis for 4502.T.